Claim 1

Xcare produces measurable economic value for a clinic, confirmed in the clinic's own records, at a cost the clinic keeps paying for.

Evidenced (value); retention pending

Why it matters

This is the base of the business and the definition of "patients, not leads." A clinic does not buy marketing; it buys attended new patients, reactivated patients, kept appointments and retained production. If Xcare cannot show that value in the clinic's own PMS — and the clinic does not renew — nothing above this layer matters. It is also the foundation for performance pricing and for every Market economics figure.

Evidence required

Per clinic per month — attended new patients attributed to Xcare; reactivated (overdue → attended) patients; confirmation-driven no-show reduction; clinic-reported production from those patients (or an explicitly labelled external benchmark); Xcare fee and Xcare delivery cost; and, as the revealed-preference test, clinic retention and expansion (second locations, upsells).

Current evidence

Client Report (trailing 18 months, 24 included clinics of 29 active): 2,340 PMS-confirmed attended new patients {ACTUAL}; $9.6M of PMS production attributed to those patients {ACTUAL}; median clinic value ratio 9.0x spend, 96% of clinics >=2x {CALCULATED}; aggregate cost to clinic per attended patient $134, median $216 {CALCULATED}. Two clinics produce approximately 60% of attributed production; one clinic is below 1x; three clinics are excluded pending attribution review.

What would invalidate this claim

A clinic value ratio below ~2× for a majority of clinics over 6+ months, or 12-month logo retention below ~70% with ROI cited as the churn reason.

Clinic value ratio by clinic (24 included clinics)
ClinicModelAttended patientsValue ratioCost per attended patient
Clinic D-01Managed (fixed budget)330128.8×$77
Clinic D-02Managed (fixed budget)411112.7×$55
Clinic D-03Growth13877.7×$76
Clinic D-04Growth4837.6×$286
Clinic D-05Managed (fixed budget)16930.8×$143
Clinic D-06Growth6217.4×$121
Clinic D-07Growth5316.2×$209
Clinic D-08Growth11014.4×$197
Clinic D-10Growth15712.7×$67
Clinic D-11Growth2710.9×$389
Clinic D-12Growth8210.5×$128
Clinic D-13Managed (fixed budget)5410.2×$222
Clinic D-14Growth677.8×$166
Clinic D-16Growth467.3×$232
Clinic D-17Growth196.9×$711
Clinic D-18Growth396.3×$269
Clinic D-19Growth2126.1×$50
Clinic D-20Managed (fixed budget)355.7×$257
Clinic D-21Growth224.2×$489
Clinic D-22Growth313.5×$436
Clinic D-23Growth133.4×$854
Clinic D-24Growth123.2×$920
Clinic D-26Growth1832.5×$57
Clinic D-28Growth200.6×$525

Attributed production divided by the clinic's spend with Xcare. Log scale; the 1× line is break-even for the clinic and the 2× line is the threshold we hold ourselves to.

Client Report, 2026-09-16, trailing 18 months

Growth modelManaged (fixed budget)ACTUAL and CALCULATED values only

3 of 27 clinics with readable counts are excluded pending attribution review (cost per attended patient ≥ $2,700 on ≤5 acquisitions). They are listed, greyed, in the verified evidence table.

Cost to the clinic per attended patient — distribution
ClinicModelAttended patientsValue ratioCost per attended patient
Clinic D-01Managed (fixed budget)330128.8×$77
Clinic D-02Managed (fixed budget)411112.7×$55
Clinic D-03Growth13877.7×$76
Clinic D-04Growth4837.6×$286
Clinic D-05Managed (fixed budget)16930.8×$143
Clinic D-06Growth6217.4×$121
Clinic D-07Growth5316.2×$209
Clinic D-08Growth11014.4×$197
Clinic D-10Growth15712.7×$67
Clinic D-11Growth2710.9×$389
Clinic D-12Growth8210.5×$128
Clinic D-13Managed (fixed budget)5410.2×$222
Clinic D-14Growth677.8×$166
Clinic D-16Growth467.3×$232
Clinic D-17Growth196.9×$711
Clinic D-18Growth396.3×$269
Clinic D-19Growth2126.1×$50
Clinic D-20Managed (fixed budget)355.7×$257
Clinic D-21Growth224.2×$489
Clinic D-22Growth313.5×$436
Clinic D-23Growth133.4×$854
Clinic D-24Growth123.2×$920
Clinic D-26Growth1832.5×$57
Clinic D-28Growth200.6×$525

One dot per clinic. Median $216, P25 $110, P75 $401; 75% of included clinics are under $400. Log scale.

Client Report, 2026-09-16, trailing 18 months

Growth modelManaged (fixed budget)ACTUAL and CALCULATED values only

3 of 27 clinics with readable counts are excluded pending attribution review (cost per attended patient ≥ $2,700 on ≤5 acquisitions). They are listed, greyed, in the verified evidence table.

Full evidence template — verified

Assumptions, risks, data still needed, supporting metrics and charts are available in the Investor Room.

Request access →

← Back to the thesis